Home > Research > Publications & Outputs > Health economics and cost of illness in Parkins...

Research

Links

Text available via DOI:

Keywords

View graph of relations

Health economics and cost of illness in Parkinson's disease

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

Health economics and cost of illness in Parkinson's disease. / Mateus, Céu; Coloma, Joana.
In: European Neurological Review, Vol. 8, No. 1, 01.12.2013, p. 6-9.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Mateus, C & Coloma, J 2013, 'Health economics and cost of illness in Parkinson's disease', European Neurological Review, vol. 8, no. 1, pp. 6-9. https://doi.org/10.17925/ENR.2013.08.01.6

APA

Mateus, C., & Coloma, J. (2013). Health economics and cost of illness in Parkinson's disease. European Neurological Review, 8(1), 6-9. https://doi.org/10.17925/ENR.2013.08.01.6

Vancouver

Mateus C, Coloma J. Health economics and cost of illness in Parkinson's disease. European Neurological Review. 2013 Dec 1;8(1):6-9. doi: 10.17925/ENR.2013.08.01.6

Author

Mateus, Céu ; Coloma, Joana. / Health economics and cost of illness in Parkinson's disease. In: European Neurological Review. 2013 ; Vol. 8, No. 1. pp. 6-9.

Bibtex

@article{9f3736fe1d094e57a3b42ac893525d92,
title = "Health economics and cost of illness in Parkinson's disease",
abstract = "Parkinson's disease (PD) is the second most common neurodegenerative disorder worldwide. With a progressive course and no cure yet available, it is demanding for patients and their caregivers, but also for health and social support systems and ultimately for society as a whole. Everyday significant economic resources are spent due to PD, either directly on its treatment or in lost productivity. In this article, one tried to frame PD from an health economics' perspective and cost of illness studies conducted in 11 countries (Austria, Czech Republic, Finland, France, Germany, Italy, Portugal, Russia, Sweden, UK and US), published from 1998 to 2011, were reviewed. One main aspect subsists: costs associated with this disorder are high, disproportionately higher that its prevalence and PD poses a substantial economic burden on individuals and society.",
keywords = "Cost of illness, Indirect costs burden of disease, Parkinson's disease",
author = "C{\'e}u Mateus and Joana Coloma",
year = "2013",
month = dec,
day = "1",
doi = "10.17925/ENR.2013.08.01.6",
language = "English",
volume = "8",
pages = "6--9",
journal = "European Neurological Review",
issn = "1758-3837",
publisher = "Touch Briefings",
number = "1",

}

RIS

TY - JOUR

T1 - Health economics and cost of illness in Parkinson's disease

AU - Mateus, Céu

AU - Coloma, Joana

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Parkinson's disease (PD) is the second most common neurodegenerative disorder worldwide. With a progressive course and no cure yet available, it is demanding for patients and their caregivers, but also for health and social support systems and ultimately for society as a whole. Everyday significant economic resources are spent due to PD, either directly on its treatment or in lost productivity. In this article, one tried to frame PD from an health economics' perspective and cost of illness studies conducted in 11 countries (Austria, Czech Republic, Finland, France, Germany, Italy, Portugal, Russia, Sweden, UK and US), published from 1998 to 2011, were reviewed. One main aspect subsists: costs associated with this disorder are high, disproportionately higher that its prevalence and PD poses a substantial economic burden on individuals and society.

AB - Parkinson's disease (PD) is the second most common neurodegenerative disorder worldwide. With a progressive course and no cure yet available, it is demanding for patients and their caregivers, but also for health and social support systems and ultimately for society as a whole. Everyday significant economic resources are spent due to PD, either directly on its treatment or in lost productivity. In this article, one tried to frame PD from an health economics' perspective and cost of illness studies conducted in 11 countries (Austria, Czech Republic, Finland, France, Germany, Italy, Portugal, Russia, Sweden, UK and US), published from 1998 to 2011, were reviewed. One main aspect subsists: costs associated with this disorder are high, disproportionately higher that its prevalence and PD poses a substantial economic burden on individuals and society.

KW - Cost of illness

KW - Indirect costs burden of disease

KW - Parkinson's disease

U2 - 10.17925/ENR.2013.08.01.6

DO - 10.17925/ENR.2013.08.01.6

M3 - Journal article

AN - SCOPUS:84893062014

VL - 8

SP - 6

EP - 9

JO - European Neurological Review

JF - European Neurological Review

SN - 1758-3837

IS - 1

ER -